INY-03-041
Product Specifications
Target
Akt|||PROTACs
Related Pathways
PROTAC|||PI3K/Akt/mTOR signaling|||Cytoskeletal Signaling
Bioactivity
INY-03-041, a potent and highly selective PROTAC-based pan-AKT degrader, inhibits AKT1, AKT2, and AKT3 with IC50s of 2.0 nM, 6.8 nM, and 3.5 nM, respectively. This compound consists of the ATP-competitive AKT inhibitor GDC-0068 conjugated to Lenalidomide.
Smiles
O=C(C(N(CC1=C2C=CC=C1CCCCCCCCCCNC[C@H](C3=CC=C(Cl)C=C3)C(N4CCN(C5=C([C@H](C)C[C@H]6O)C6=NC=N5)CC4)=O)C2=O)CC7)NC7=O
Molecular Formula
C44H56ClN7O5
Molecular Weight
798.41
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1346056-01 0.02 mg (E-Coli)
Recombinant Ehrlichia canis DNA-directed RNA polymerase subunit omega (rpoZ)
Ask
View Details 
MBS1346056-02 0.1 mg (E-Coli)
Recombinant Ehrlichia canis DNA-directed RNA polymerase subunit omega (rpoZ)
Ask
View Details 
MBS1346056-03 0.02 mg (Yeast)
Recombinant Ehrlichia canis DNA-directed RNA polymerase subunit omega (rpoZ)
Ask
View Details MBS1346056-04 0.1 mg (Yeast)
Recombinant Ehrlichia canis DNA-directed RNA polymerase subunit omega (rpoZ)
Ask
View Details MBS1346056-05 0.02 mg (Baculovirus)
Recombinant Ehrlichia canis DNA-directed RNA polymerase subunit omega (rpoZ)
Ask
View Details